A population model capturing dynamics of tuberculosis granulomas predicts host infection outcomes

  • Received: 01 January 2015 Accepted: 29 June 2018 Published: 01 February 2015
  • MSC : Primary: 97M60; Secondary: 92B05.

  • Granulomas play a centric role in tuberculosis (TB) infection progression. Multiple granulomas usually develop within a single host. These granulomas are not synchronized in size or bacteria load, and will follow different trajectories over time. How the fate of individual granulomas influence overall infection outcome at host scale is not understood, although computational models have been developed to predict single granuloma behavior. Here we present a within-host population model that tracks granulomas in two key organs during Mycobacteria tuberculosis (Mtb) infection: lung and lymph nodes (LN). We capture various time courses of TB progression, including latency and reactivation. The model predicts that there is no steady state; rather it is a continuous process of progressing to active disease over differing time periods. This is consistent with recently posed ideas suggesting that latent TB exists as a spectrum of states and not a single state. The model also predicts a dual role for granuloma development in LNs during Mtb infection: in early phases of infection granulomas suppress infection by providing additional antigens to the site of immune priming; however, this induces a more rapid reactivation at later stages by disrupting immune responses. We identify mechanisms that strongly correlate with better host-level outcomes, including elimination of uncontained lung granulomas by inducing low levels of lung tissue damage and inhibition of bacteria dissemination within the lung.

    Citation: Chang Gong, Jennifer J. Linderman, Denise Kirschner. A population model capturing dynamics of tuberculosis granulomas predicts host infection outcomes[J]. Mathematical Biosciences and Engineering, 2015, 12(3): 625-642. doi: 10.3934/mbe.2015.12.625

    Related Papers:

  • Granulomas play a centric role in tuberculosis (TB) infection progression. Multiple granulomas usually develop within a single host. These granulomas are not synchronized in size or bacteria load, and will follow different trajectories over time. How the fate of individual granulomas influence overall infection outcome at host scale is not understood, although computational models have been developed to predict single granuloma behavior. Here we present a within-host population model that tracks granulomas in two key organs during Mycobacteria tuberculosis (Mtb) infection: lung and lymph nodes (LN). We capture various time courses of TB progression, including latency and reactivation. The model predicts that there is no steady state; rather it is a continuous process of progressing to active disease over differing time periods. This is consistent with recently posed ideas suggesting that latent TB exists as a spectrum of states and not a single state. The model also predicts a dual role for granuloma development in LNs during Mtb infection: in early phases of infection granulomas suppress infection by providing additional antigens to the site of immune priming; however, this induces a more rapid reactivation at later stages by disrupting immune responses. We identify mechanisms that strongly correlate with better host-level outcomes, including elimination of uncontained lung granulomas by inducing low levels of lung tissue damage and inhibition of bacteria dissemination within the lung.


    加载中
    [1] Environmental health perspectives, 55 (1984), 25-36.
    [2] Nature reviews. Microbiology, 7 (2009), 845-855.
    [3] Nature Medicine, 1 (1995), 815-821.
    [4] Inflammation & allergy drug targets, 6 (2007), 27-39.
    [5] Mathematical Biosciences and Engineering, 6 (2009), 209-237.
    [6] Journal of mathematical biology, 35 (1997), 629-656.
    [7] Infection and Immunity, 70 (2002), 4501-4509.
    [8] PloS one, 8 (2013), e68680.
    [9] Sci Transl Med, 6 (2014), p265ra167.
    [10] The American review of respiratory disease, 133 (1986), 321-340.
    [11] Archives of internal medicine, 163 (2003), 1009-1021.
    [12] 2004.
    [13] Journal of the Royal Society, Interface / the Royal Society, 7 (2010), 873-885.
    [14] The Lancet, 352 (1998), 1886-1891.
    [15] Journal of immunology (Baltimore, Md. : 1950), 188 (2012), 3169-3178.
    [16] Frontiers in physiology, 2012.
    [17] PLoS computational biology, 6 (2010), e1000778, 19pp.
    [18] Theoretical population biology, 57 (2000), 235-247.
    [19] Annual review of immunology, 19 (2001), 93-129.
    [20] Journal of theoretical biology, 335 (2013), 169-184.
    [21] Journal of theoretical biology, 289 (2011), 197-205.
    [22] Theoretical population biology, 55 (1999), 94-109.
    [23] Immunological reviews, 216 (2007), 93-118.
    [24] Antimicrobial agents and chemotherapy, 57 (2013), 4237-4244.
    [25] Nature medicine, 20 (2014), 75-79.
    [26] Infection and immunity, 77 (2009), 4631-4642.
    [27] Journal of immunology (Baltimore, Md. : 1950), 184 (2010), 2873-2885.
    [28] Mathematical biosciences and engineering : MBE, 3 (2006), 661-682.
    [29] Journal of theoretical biology, 292 (2012), 44-59.
    [30] Journal of theoretical biology, 280 (2011), 50-62.
    [31] Journal of theoretical biology, 254 (2008), 178-196.
    [32] Journal of theoretical biology, 227 (2004), 463-486.
    [33] Wiley interdisciplinary reviews. Systems biology and medicine, 3 (2011), 479-489.
    [34] SIAM Journal on Applied Mathematics, 62 (2002), 1634-1656.
    [35] Mathematical Biosciences, 180 (2002), 161-185.
    [36] Journal of Theoretical Biology, 223 (2003), 391-404.
    [37] Annual review of immunology, 31 (2013), 475-527.
    [38] 2013.
    [39] Int Rev Cytol, 128 (1991), 215-260.
    [40] Science, 329 (2010), 538-541.
    [41] Nature reviews. Immunology, 12 (2012), 352-366.
    [42] Proceedings of the National Academy of Sciences of the United States of America, 102 (2005), 8327-8332.
    [43] Journal of theoretical biology, 231 (2004), 357-376.
    [44] Mathematical biosciences and engineering: MBE, 1 (2004), 81-93.
    [45] Infection and immunity, 81 (2013), 2909-2919.
    [46] The Journal of Immunology, 166 (2001), 1951-1967.
    [47] The Journal of Immunology, 168 (2002), 4968-4979.
    [48] Nature reviews. Microbiology, 6 (2008), 520-528.
  • Reader Comments
  • © 2015 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Metrics

Article views(491) PDF downloads(519) Cited by(10)

Article outline

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return

Catalog